Search - Archive ouverte HAL Access content directly

Filter your results

25 Results
Structure: Internal structure identifier : 463769

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

Steven Le Gouill , Catherine Thieblemont , Lucie Oberic , Anne Moreau , Krimo Bouabdallah et al.
New England Journal of Medicine, 2017, 377 (13), pp.1250-1260. ⟨10.1056/NEJMoa1701769⟩
Journal articles hal-02329536v1
Image document

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma

Maroulio Pertesi , Maxime Vallée , Xiaomu Wei , Maria Revuelta , Perrine Galia et al.
Leukemia, 2019, 33 (9), pp.2324-2330. ⟨10.1038/s41375-019-0452-6⟩
Journal articles hal-02190723v1

Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group

Thorsten Braun , Sophie Cereja , Sylvie Chevret , Emmanuel Raffoux , Marie Beaumont et al.
Cancer, 2015, 121 (14), pp.2393-2399. ⟨10.1002/cncr.29389⟩
Journal articles hal-01237097v1

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

Marie-Hélène Delfau-Larue , Wolfram Klapper , Françoise Berger , Fabrice Jardin , Josette Brière et al.
Blood, 2015, 126 (5), pp.604-611. ⟨10.1182/blood-2015-02-628792⟩
Journal articles hal-02331700v1
Image document

Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.

Christiane Copie-Bergman , Philippe Gaulard , Karen Leroy , Josette Briere , Maryse Baia et al.
Journal of Clinical Oncology, 2009, 27 (33), pp.5573-9. ⟨10.1200/JCO.2009.22.7058⟩
Journal articles inserm-00424929v1

Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study

Maël Heiblig , Delphine Rea , Marie-Lorraine Chrétien , Aude Charbonnier , Philippe Rousselot et al.
Experimental Hematology, 2018, 67, pp.41 - 48. ⟨10.1016/j.exphem.2018.08.006⟩
Journal articles hal-01927788v1
Image document

Éligibilité des patients aux cellules CAR-T : avis d’experts proposé par la SFGM-TC

David Beauvais , Emmanuel Bachy , André Baruchel , Jacques-Olivier Bay , Denis Caillot et al.
Bulletin du Cancer, 2021, 108 (7-8), pp.725-729. ⟨10.1016/j.bulcan.2020.10.017⟩
Journal articles inserm-03349011v1

Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study.

Pauline Peyrouze , Soizic Guihard , Nathalie Grardel , Céline Berthon , Nicolas Pottier et al.
British Journal of Haematology, 2012, 159 (5), pp.599-602. ⟨10.1111/bjh.12063⟩
Journal articles hal-00849681v1
Image document

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study

Rene-Olivier Casasnovas , Reda Bouabdallah , Pauline Brice , Julien Lazarovici , Hervé Ghesquieres et al.
Lancet Oncology, 2019
Journal articles hal-01996114v1

Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study

Fabrice Jardin , Jean-Philippe Jais , Thierry-Jo Molina , Françoise Parmentier , Jean-Michel Picquenot et al.
Blood, 2010, 116 (7), pp.1092-1104
Journal articles ensl-00816038v1

Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study

Hervé Tilly , Franck Morschhauser , Olivier Casasnovas , Thierry Jo Molina , Pierre Feugier et al.
The Lancet Haematology, 2018, 5 (9), pp.e403-e410. ⟨10.1016/S2352-3026(18)30131-5⟩
Journal articles hal-02329073v1

Recommandations 2015 du France Intergroupe des Leucémies Myéloïdes Chroniques pour la gestion du risque d'événements cardiovasculaires sous nilotinib au cours de la leucémie myéloïde chronique

Delphine Rea , Shanti Ame , Aude Charbonnier , Valérie Coiteux , Pascale Cony-Makhoul et al.
Bulletin du Cancer, 2016, 103 (2), pp.180-189. ⟨10.1016/j.bulcan.2015.11.008⟩
Journal articles hal-01800007v1
Image document

BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab

Sarah Huet , Edith Szafer-Glusman , Bruno Tesson , Luc Xerri , Wayne J. Fairbrother et al.
American Journal of Hematology, 2017, 92 (6), pp.515 - 519. ⟨10.1002/ajh.24701⟩
Journal articles hal-01524901v1

Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group

Sophie Michallet , Arnaud Campidelli , Helene Lequeu , Marie-Sarah Dilhuydy , Olivier Tournilhac et al.
American Journal of Hematology, 2017, 92 (6), pp.E105 - E107. ⟨10.1002/ajh.24715⟩
Journal articles hal-01653723v1
Image document

Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.

Sophie Ducastelle , Lionel Adès , Claude Gardin , Hervé Dombret , Thomas Prébet et al.
Haematologica, 2006, 91 (3), pp.373-6
Journal articles inserm-00473474v1

Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant

Natacha Heutte , Corinne Haioun , Pierre Feugier , Bertrand Coiffier , Herve Tilly et al.
Leukemia & lymphoma, 2011, 52 (7), pp.1239-1248. ⟨10.3109/10428194.2011.566951⟩
Journal articles hal-02358618v1
Image document

The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.

Jean-Philippe Jais , Corine Haioun , Thierry J. Molina , David S. Rickman , Aurélien de Reynies et al.
Leukemia, 2008, 22 (10), pp.1917-24. ⟨10.1038/leu.2008.188⟩
Journal articles inserm-00339565v1

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC–GELA H8 randomised controlled trial

Natacha Heutte , Henning Flechtner , Nicolas Mounier , Wilhelmina Am Mellink , Jacobus Meerwaldt et al.
Lancet Oncology, 2009, 10 (12), pp.1160-1170. ⟨10.1016/S1470-2045(09)70258-X⟩
Journal articles hal-02359039v1
Image document

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts

Sarah Huet , Bruno Tesson , Jean-Philippe Jais , Andrew Feldman , Laura Magnano et al.
Lancet Oncology, 2018, 19 (4), pp.549 - 561. ⟨10.1016/S1470-2045(18)30102-5⟩
Journal articles hal-01788996v1

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC / PVT1 predicts patient outcome in two independent cohorts

Hervé Ghesquières , Beth R. Larrabee , Olivier Casasnovas , Matthew Maurer , James D. Mckay et al.
British Journal of Haematology, 2018, 180 (2), pp.286 - 290. ⟨10.1111/bjh.14306⟩
Journal articles hal-01728832v1

Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity

Na Li , Pierre Feugier , Brigitte Serrurrier , Véronique Latger-Cannard , Jean-François Lesesve et al.
Experimental Hematology, 2007, 35 (3), pp.507-515. ⟨10.1016/j.exphem.2006.10.015⟩
Journal articles istex hal-01980962v1

Outcome of common iliac arteries after straight aortic tube-graft placement during elective repair of infrarenal abdominal aortic aneurysms.

Réda Hassen-Khodja , Patrick Feugier , Jean-Pierre Favre , André Nevelsteen , José Ferreira et al.
Journal of Vascular Surgery, 2006, 44 (5), pp.943-8. ⟨10.1016/j.jvs.2006.06.043⟩
Journal articles ujm-00440341v1

A fixed-duration, measurable residual disease–guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial

Anne-Sophie Michallet , Rémi Letestu , Magali Le Garff-Tavernier , Carmen Aanei , Michel Ticchioni et al.
Blood, 2021, 137 (8), pp.1019-1023. ⟨10.1182/blood.2020008164⟩
Journal articles hal-03231146v1

Ten-Year Relative Survival and Causes of Death in Elderly Patients Treated With R-CHOP or CHOP in the GELA LNH-985 Trial

Nicolas Mounier , Natacha Heutte , Catherine Thiéblemont , Josette Brière , Philippe Gaulard et al.
Clinical Lymphoma Myeloma and Leukemia, 2012, 12 (3), pp.151-154. ⟨10.1016/j.clml.2011.11.004⟩
Journal articles hal-02358962v1

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study

Rene-Olivier Casasnovas , Reda Bouabdallah , Pauline Brice , Julien Lazarovici , Hervé Ghesquieres et al.
Lancet Oncology, 2019, 20 (2), pp.202-215. ⟨10.1016/S1470-2045(18)30784-8⟩
Journal articles hal-02263798v1